146 related articles for article (PubMed ID: 33184000)
1. Health Care Resource Utilization and Costs Among Medicare Beneficiaries Newly Diagnosed With Peripheral T-cell Lymphoma: A Retrospective Claims Analysis.
Shah A; Petrilla A; Rebeira M; Feliciano J; Lisano J; LeBlanc TW
Clin Lymphoma Myeloma Leuk; 2021 Jan; 21(1):e1-e9. PubMed ID: 33184000
[TBL] [Abstract][Full Text] [Related]
2. Real-world treatment patterns, healthcare resource utilization and costs among patients with peripheral T-cell lymphoma.
Dharmani C; Unni S; Pham N; Shaikh NF; Xiong Y; Vashi R; Fofah O; Strubing A; Salas M; Tu N; Wooddell M; Zhou X; Near A
Future Oncol; 2024 May; 20(15):1013-1030. PubMed ID: 37814886
[TBL] [Abstract][Full Text] [Related]
3. Clinical and economic burden of peripheral T-cell lymphoma in commercially insured patients in the United States: findings using real-world claims data.
Burudpakdee C; Lin HM; Wang W; Seetasith A; Zhu Y; Bonthapally V; Carson KR
J Med Econ; 2016 Oct; 19(10):965-72. PubMed ID: 27152635
[TBL] [Abstract][Full Text] [Related]
4. Burden of illness and treatment patterns among patients with peripheral T-cell lymphoma in the US healthcare setting.
Petrilla AA; Shah A; Feliciano J; Woolery J; LeBlanc TW
Curr Med Res Opin; 2021 Jul; 37(7):1189-1197. PubMed ID: 33944646
[TBL] [Abstract][Full Text] [Related]
5. Real-world burden of illness and unmet need in locally advanced or metastatic urothelial carcinoma following discontinuation of PD-1/L1 inhibitor therapy: A Medicare claims database analysis.
Morgans AK; Hepp Z; Shah SN; Shah A; Petrilla A; Small M; Sonpavde G
Urol Oncol; 2021 Oct; 39(10):733.e1-733.e10. PubMed ID: 34238657
[TBL] [Abstract][Full Text] [Related]
6. Health care resource utilization and costs of recurrent
Nelson WW; Scott TA; Boules M; Teigland C; Parente A; Unni S; Feuerstadt P
J Manag Care Spec Pharm; 2021 Jul; 27(7):828-838. PubMed ID: 33703939
[No Abstract] [Full Text] [Related]
7. Administration costs of intravenous chemotherapy in treating peripheral T-cell lymphoma.
Kruse GB; Potashman MH; Stavrakas S; Wong BJ
J Med Econ; 2014 Jul; 17(7):446-58. PubMed ID: 24758228
[TBL] [Abstract][Full Text] [Related]
8. Medicare fee-for-service enrollees with primary acute myeloid leukemia: an analysis of treatment patterns, survival, and healthcare resource utilization and costs.
Meyers J; Yu Y; Kaye JA; Davis KL
Appl Health Econ Health Policy; 2013 Jun; 11(3):275-86. PubMed ID: 23677706
[TBL] [Abstract][Full Text] [Related]
9. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
[TBL] [Abstract][Full Text] [Related]
10. Health Care Resource Utilization and Total Costs of Care for Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia in the United States: A Retrospective Claims Analysis.
Ito D; Feng C; Fu C; Kim C; Wu J; Dalton D; Epstein J; Snider JT; DuVall AS
Clin Ther; 2024 Jan; 46(1):3-11. PubMed ID: 37981560
[TBL] [Abstract][Full Text] [Related]
11. Retrospective database analysis of healthcare resource utilization and costs in patients who develop post-transplant lymphoproliferative disease within the first year following allogeneic hematopoietic stem cell transplants.
Watson C; Xu H; Princic N; Sruti I; Barlev A
J Med Econ; 2020 Oct; 23(10):1159-1167. PubMed ID: 32643493
[TBL] [Abstract][Full Text] [Related]
12. Association between the Medicare hospice benefit and health care utilization and costs for patients with poor-prognosis cancer.
Obermeyer Z; Makar M; Abujaber S; Dominici F; Block S; Cutler DM
JAMA; 2014 Nov; 312(18):1888-96. PubMed ID: 25387186
[TBL] [Abstract][Full Text] [Related]
13. Influence of treatment intensity and medical comorbidities in older adults with peripheral T cell lymphoma.
Gordon MJ; Duan Z; Zhao H; Nastoupil L; Ng S; Danilov AV; Iyer S; Giordano SH
Leuk Lymphoma; 2023 Dec; 64(14):2258-2268. PubMed ID: 37706491
[TBL] [Abstract][Full Text] [Related]
14. Patient Characteristics and Costs Associated With COVID-19-Related Medical Care Among Medicare Fee-for-Service Beneficiaries.
Tsai Y; Vogt TM; Zhou F
Ann Intern Med; 2021 Aug; 174(8):1101-1109. PubMed ID: 34058109
[TBL] [Abstract][Full Text] [Related]
15. Reduced mortality, complications, and economic burden among medicare beneficiaries receiving influenza antivirals.
Best JH; Reddy SR; Chang E; Bognar K; Tarbox MH; Cagas SE; Seetasith A
J Med Econ; 2024; 27(1):240-252. PubMed ID: 38294309
[TBL] [Abstract][Full Text] [Related]
16. Association Between Hospice Length of Stay, Health Care Utilization, and Medicare Costs at the End of Life Among Patients Who Received Maintenance Hemodialysis.
Wachterman MW; Hailpern SM; Keating NL; Kurella Tamura M; O'Hare AM
JAMA Intern Med; 2018 Jun; 178(6):792-799. PubMed ID: 29710217
[TBL] [Abstract][Full Text] [Related]
17. Treatment patterns, adverse events, healthcare resource use and costs among commercially insured patients with mantle cell lymphoma in the United States.
Kabadi SM; Near A; Wada K; Burudpakdee C
Cancer Med; 2019 Dec; 8(17):7174-7185. PubMed ID: 31595715
[TBL] [Abstract][Full Text] [Related]
18. Direct economic burden of high-risk and metastatic melanoma in the elderly: evidence from the SEER-Medicare linked database.
Davis KL; Mitra D; Kotapati S; Ibrahim R; Wolchok JD
Appl Health Econ Health Policy; 2009; 7(1):31-41. PubMed ID: 19558193
[TBL] [Abstract][Full Text] [Related]
19. Peripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapy.
Abramson JS; Feldman T; Kroll-Desrosiers AR; Muffly LS; Winer E; Flowers CR; Lansigan F; Nabhan C; Nastoupil LJ; Nath R; Goy A; Castillo JJ; Jagadeesh D; Woda B; Rosen ST; Smith SM; Evens AM
Ann Oncol; 2014 Nov; 25(11):2211-2217. PubMed ID: 25193992
[TBL] [Abstract][Full Text] [Related]
20. Antipsychotic utilization, healthcare resource use and costs, and quality of care among fee-for-service Medicare beneficiaries with schizophrenia in the United States.
Li P; Benson C; Geng Z; Seo S; Patel C; Doshi JA
J Med Econ; 2023; 26(1):525-536. PubMed ID: 36961119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
